Cargando…

Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials

PURPOSE: To evaluate 1-year efficacy, durability, and safety of faricimab among patients from Asian countries in the TENAYA/LUCERNE trials of neovascular age-related macular degeneration (nAMD). METHODS: Treatment-naïve patients with nAMD were randomly assigned (1:1) to faricimab 6.0 mg up to every...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Kanji, Cheung, Chui Ming Gemmy, Iida, Tomohiro, Lai, Timothy Y. Y., Ohji, Masahito, Yanagi, Yasuo, Kawano, Mika, Ohsawa, Shino, Suzuki, Tomoyuki, Kotecha, Aachal, Lin, Hugh, Patel, Vaibhavi, Swaminathan, Balakumar, Lee, Won Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251323/ https://www.ncbi.nlm.nih.gov/pubmed/37294433 http://dx.doi.org/10.1007/s00417-023-06071-8

Ejemplares similares

TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
por: Khanani, Arshad M., et al.
Publicado: (2021)

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
por: Ohji, Masahito, et al.
Publicado: (2021)

Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole
por: Fujikawa, Masato, et al.
Publicado: (2013)

Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial
por: Mori, Ryusaburo, et al.
Publicado: (2023)

Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)
por: Sakamoto, Taiji, et al.
Publicado: (2021)

An AI model to estimate visual acuity based solely on cross-sectional OCT imaging of various diseases
por: Inoda, Satoru, et al.
Publicado: (2023)

Visualization of retinal breaks on ultra-widefield fundus imaging using a digital green filter
por: Moon, Jade Y., et al.
Publicado: (2022)

Pars plana vitrectomy for the repair of primary, inferior rhegmatogenous retinal detachment associated to inferior breaks. A comparison of a 25-gauge versus a 20-gauge system
por: dell’Omo, Roberto, et al.
Publicado: (2012)

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy
por: Yamakiri, Keita, et al.
Publicado: (2008)

Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial
por: Hoerauf, Hans, et al.
Publicado: (2011)

Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
por: Fortunato, Pina, et al.
Publicado: (2009)

The effect of a preoperative subconjuntival injection of dexamethasone on blood–retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial
por: Bali, Ernesto, et al.
Publicado: (2010)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Pattern recognition can detect subtle field defects in eyes of HIV individuals without retinitis under HAART
por: Goldbaum, Michael H., et al.
Publicado: (2010)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
por: Fassnacht-Riederle, Heidi, et al.
Publicado: (2014)

Posterior vitreous detachment following intravitreal drug injection
por: Geck, Ulrich, et al.
Publicado: (2013)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G–assisted chromovitrectomy?
por: Henrich, Paul B., et al.
Publicado: (2013)

Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
por: Dmuchowska, Diana Anna, et al.
Publicado: (2013)

Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014)

A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit)
por: Stalmans, Peter
Publicado: (2016)

Photopic full-field electroretinography and optical coherence tomography in type 1 diabetic retinopathy
por: Jansson, Ragnhild Wivestad, et al.
Publicado: (2015)

Detecting signs of retinal leakage in exudative AMD using Cirrus OCT versus SL SCAN-1, a novel integrated FD-OCT into a common slit lamp
por: Stehouwer, M., et al.
Publicado: (2015)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
por: Korobelnik, Jean-François, et al.
Publicado: (2016)

Investigation of precursor lesions of polypoidal choroidal vasculopathy using contralateral eye findings
por: Kang, Se Woong, et al.
Publicado: (2016)

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
por: Eter, Nicole, et al.
Publicado: (2016)

EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study
por: Tan, Colin S., et al.
Publicado: (2016)

Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
por: Gawęcki, Maciej, et al.
Publicado: (2017)

Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
por: Parvin, Parmis, et al.
Publicado: (2017)

Combined in-depth, 3D, en face imaging of the optic disc, optic disc pits and optic disc pit maculopathy using swept-source megahertz OCT at 1050 nm
por: Maertz, Josef, et al.
Publicado: (2017)

Fixation behavior in macular dystrophy assessed by microperimetry
por: Chiang, Wei-Yu, et al.
Publicado: (2018)

Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study
por: Gao, Tingting, et al.
Publicado: (2018)

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy
por: Chen, Ling, et al.
Publicado: (2018)

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
por: Li, Xiaoxin, et al.
Publicado: (2017)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
por: Karst, Sonja G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_htu150nkq9imge2m7383aloss2